Only 5% of cancer patients enroll in oncology clinical trials today because the majority of oncologists don’t participate Read More
N-Power Medicine raises Series B funding, partners with Merck
Only 5% of cancer patients enroll in oncology clinical trials today because the majority of oncologists don’t participate Read More